JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.86 CNY | -3.65% |
|
-3.79% | -23.01% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD. is principally engaged in the research, development, production and distribution of Chinese patent drugs for the treatment of cardiovascular and cerebrovascular disease. The Companyâs main products consist of Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections and Guifu Dihuang capsules, among others. The Company's products are applied in the treatment for heart cerebrovascular diseases and detoxification. The company also provides health care products and cosmetics. The Company distributes its products within China market.
Sector
Pharmaceuticals
Calendar
2024-05-10
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -23.01% | 313M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 002566 Stock
- News Jilin Jian Yisheng Pharmaceutical Co., Ltd.
- China's Procurement Office Selects Jilin Jian Yisheng Pharmaceutical Drug for Centralized Procurement
